VEGFA and neoplasm: STAT3 and STAT5 have been reported to act by inhibiting the antitumor immune response by activating, at least in part, the production of inflammatory cytokines (IL-1, IL-17, IL-10, TGF-β, or VEGF) and promoting tumor growth and metastasis (150).